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Jefferson Awards
Gala Celebrates
a Dedicated
Faculty Member
On October 22, 2009, the
Jefferson community celebrated
the contributions of Herbert E.
Cohn, MD, FACS, at the Seventh
Annual Jefferson Awards Gala. Dr.
Cohn, a Jefferson Medical College
alumnus, distinguished member of
the Department of Surgery faculty,
teacher and administrative leader,
received the Achievement Award in
Medicine, recognizing his career in
thoracic and endocrine surgery.
More than 500 guests attended
the event which raised close to
$600,000 for Jefferson. Among the
many alumni, faculty and friends who
generously supported the Gala was
Mrs. Irmine Pilmes, a longtime patient
of Dr. Cohn’s. Dr. Cohn cared for
both she and her husband, Alexander
Bondaretz, over many years and
earned their deep appreciation. When
Mrs. Pilmes learned of the Gala,
she decided to make a significant
contribution to Jefferson in Dr.
Cohn’s honor. For Mrs. Pilmes, the
best vehicle for such a gift was
through her estate. She worked with
the Jefferson Foundation and her
attorney to develop language in her
will that would direct $100,000 to
the Department of Surgery in support
of thoracic and endocrine surgery
education and research.

Nathaniel R. Evans, MD has joined the
Division of Cardiothoracic Surgery.
Dr. Evans finished his cardiothoracic
surgery training at the Massachusetts
General Hospital in December 2009.
His focus will be on thoracic surgery
both at Thomas Jefferson University
Hospital and Methodist Hospital.
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News in Brief

Those Who Give

Nathaniel R. Evans, MD

Sun Yong (Sunny) Lee, MD, FACS

Dr. Cohn (center) accepts the Academic Achievement Award from
University President Robert Barchi, MD, PhD (left) and Tom Lewis,
TJUH President and CEO. Three generations of Dr. Cohn’s family
attended the event last fall, including his wife Natalie (below.)

The most common form of a planned
gift is a simple bequest through a
will. Bequests of cash, securities,
real property or other assets to

Jefferson entitle one’s estate to a
charitable deduction that can reduce
or eliminate estate tax liability.
Sadly, Mrs. Pilmes was unable
to attend the Gala in the fall. She
passed away during the summer, but
was recognized at the event for her
tremendous generosity as a Platinum
Sponsor. Dr. Cohn, who is currently

the Vice Chair of Quality, humbly
recalls, “I have received many gifts
from grateful patients over the years
from bottles of scotch to bequests
in their wills and I’m always taken
aback – I’m just doing my job.” At the
same time, he is very appreciative.
“It is fitting that Jefferson received
this gift. This is where I trained and
practiced my entire career. Mrs.
Pilmes’ generous gift will help ensure
that Jefferson continues to produce
top-notch surgeons and push our
research forward.”
For additional information about
planned giving, or to make a
contribution to the Department of
Surgery, please contact Lara Goldstein
in the Jefferson Foundation
at 215-955-8797 or
lara.goldstein@jefferson.edu.

has joined the Division of General Surgery. In 2005, Dr. Lee
completed a fellowship in breast surgery here at Thomas Jefferson
University Hospital. She is the Assistant Director of the new
Jefferson Breast Care Center.
Kris R. Kaulback, MD, FACS has been appointed medical director of

the trauma program at Paoli Hospital. Dr. Kaulback will also continue
as the associate director of the Level I trauma unit at Jefferson.

Adam Berger, MD, FACS, recently received an Outstanding

Performance Award for going above and beyond the scope of the
normal duties of serving as a liaison between the Hospital’s cancer
program and the American College of Surgeons Commission on
Cancer (CoC).

Nathan Richards, MD (PGY4) presented his work from Dr.

Jonathan Brody’s lab on HuR status and pancreatic cancer at the
130th Annual Meeting of the American Surgical Association in
Chicago this April.

Melissa Lazar, MD (PGY4) has won a resident research award

from the Society for Surgery of the Alimentary Tract and will
present at the May meeting on her work in Dr. Hwyda Arafat’s
lab on osteopontin and nicotine.

Steven McIlhenny, defended his PhD thesis in Jefferson’s

Tissue Engineering and Regenerative Medicine Program. Under
the mentorship of Dr. Paul J. DiMuzio, Dr. McIlhenny was
previously awarded a prestigious American Heart Association
Pre-doctoral Fellowship.

On Thursday, December 3, 2009, the portrait of Gerald J. Marks,
MD, FACS, was presented to Thomas Jefferson University. A
member of the Jefferson faculty for many years, Dr. Marks has
led a distinguished surgical career and has made numerous
contributions to the field of colorectal surgery.
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SurgicalSolutions
Kidney Transplant Program Offers Many
Options and Encourages Living Donors

Philadelphia is a competitive community
for kidney transplantation, and yet
Jefferson’s 2009 numbers were
impressive: 93 kidney and kidneypancreas transplants. “Thirty-two of these
transplanted organs were from living
donors,” says Associate Professor Carlo B.
Ramirez, MD, FACS. “The percentage of
living donors grew by 19 percent last year,
while the percentage of deceased donors
remained the same as the previous year.”
Berch Harris is a Jefferson patient who
was fortunate to know a donor with
whom he was a good match—his wife.
He met Vallerie Armstrong in 2002
when he started hemodialysis at a center
where she worked. Three years later,
Berch had regained kidney function on
two separate occasions, and he stopped
by the center with information about a
product that had helped him. Vallerie
gave him her number—it was her last
day of work there. They started dating in
2006, began doing at-home dialysis the
following spring and married in Berch’s
native Barbados on December 8, 2007.
By that time Vallerie had been tested
and deemed a match with Berch. With
his history of regaining function, Berch
remained optimistic that his kidney would
once again kick in. But those hopes were
dashed when doctors found a cancerous
tumor on his left kidney. That’s when
he and Vallerie knew it was time to get
serious about transplantation.
After having his left kidney removed
in July 2008, Berch and Vallerie moved
forward with their plan to pursue live
donor transplant. In February 2009,
Costas Lallas, MD, performed a robotic
nephrectomy on Vallerie and Dr. Ramirez
(whom she describes as “a fabulous
human being”) transplanted the kidney
to Berch. “We’re very blessed that we
have been afforded this opportunity,” says
Vallerie. “Life’s just better now, and will
continue to get better.”

A publication for
friends and
colleagues of
Jefferson’s Department
of Surgery
Spring 2010
Volume 5, Number 1

The Surgeon Speaks

Carlo Ramirez, MD, FACS

Though the heart is the universal symbol for love, for Berch and Vallerie Harris, the kidney
might be a more fitting representation of their shared affection, perseverance and faith.

Dr. Ramirez and three other Jefferson
surgeons perform kidney transplants:
Cataldo Doria, MD, PhD, FACS, the
Nicoletti Family Professor of Transplant
Surgery and Director of the Transplant
Division; Assistant Professor Adam
Frank, MD, FACS; and Associate
Professor Warren Maley, MD, who is
also Director of the Live Donor Liver
Transplantation (LDLT) Program, which
launches this spring. For patients less
fortunate than Mr. Harris, Jefferson
offers other options, including deceased
donor and paired donation protocols (see
sidebar).
Dr. Ramirez explains that, as one of
6 kidney transplant programs in the
city of Philadelphia, Jefferson strives
to maximize its patients’ chances of
receiving a donor kidney. One key to

expanding Jefferson’s transplant list is
Outreach and Education Coordinator
Kim Phillips, RN, BSN, CCTC, who goes
out to nephrology practices around the
Delaware Valley, to build relationships
and coordinate meetings with Jefferson
surgeons. “This enables us to get know
the nephrologists who refer patients to
us,” says Dr. Ramirez, “and it fosters
good communication. The day after a
transplant I always call the referring
nephrologist to let them know how their
patient is recovering,” he notes. “I find
that keeping in touch like this means a
significant amount—as it does to me with
my own patients.”
For more information about the
Kidney Transplant Program visit:

Transplantation from living donors offers
the best outcomes for patients with chronic
kidney disease. Unfortunately, only 60
percent of potential living donors are
compatible with their intended recipients.
Those patients without a compatible donor
will have to wait on the deceased donor
transplant list, which currently exceeds
85,000 patients nationally, with a median
wait time of 4 years.
To facilitate living kidney donor exchanges,
Jefferson has adopted a “paired-kidney
donation” (or “kidney donor swap”)
protocol, which will help patients with
potential living donors who are incompatible
for blood or tissue type. By collaborating
with the Paired Donation Network, we hope
to find a compatible donor-recipient pair
that will make transplant possible for most
of these recipients.
The surgery is identical to a standard living
donor kidney transplant, but there are added
considerations with a kidney exchange:
the timing of the donor operations requires
careful coordination to avoid an unfair
exchange, where one donor donates while
another potential donor does not, resulting
in only one recipient getting a transplant.

www.jeffersonhospital.org/transplant/kidney
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Overview

Changing Lives Through Research
Katie Ashburn, CRNP,
and Shawn Pierce, CNRP,

surgery fellowship at Jefferson; Pramila
Anné, MD, Associate Professor of
Radiation Oncology; Neal Flomenberg,
MD, Chair of Medical Oncology; and
Barbara Cavanaugh, MD, Clinical
Associate Professor of Radiology, in
Breast Imaging. Other critical team
members are administrator Rosanne
Iacono, RN-C, MSN, CRNP, and
coordinator Rita Battaglini, RN, BSN,
who helps patients navigate the complex
insurance system.

Charles J. Yeo, MD
Samuel D. Gross Professor and
Chair, Department of Surgery

Progress…Service Lines
Many in the Department have been involved
with our institutional efforts initiating five
robust service lines here at Jefferson.
These service lines are co-directed by a
physician and an administrator, supported
by Executive Committees and Working
Committees, and focused upon five specific
areas of clinical activity:
• Cancer
• Cardiovascular
• GI/Transplant
• Neurology/Neurosurgery
• Musculoskeletal
Our surgeons touch each of these areas,
serve on their committees, and have helped
direct initiatives dealing with quality and
outcomes, growth of services, recruitments,
marketing, etc. These service lines cross the
traditional departmental silos, bring together
physicians, surgeons and administrators
who are focused on care in the given clinical
areas, and have proved, even early in
their existence, to be valuable as we look
to grow, expand our imprint, and prepare
for Jefferson’s medicine of the future.
Of note, these service lines also provide
opportunities for focused multidisciplinary
training of our residents, students and
fellows…in one of the five clinical areas
mentioned above.
Additionally, a sixth, more “informal” service
line deals with the Multidisciplinary Center
for Critical Care. Recently new critical care
beds have been built both at the Jefferson
Hospital of Neuroscience (JHN) and on the
4th floor of the Gibbon Building, ushering in
a more robust opportunity for us to care for
the increasingly ill and complex patients that
are being treated here. As Thomas Jefferson
said in 1810, “As new discoveries are
made…institutions must advance also, and
keep pace with the times.”
Boy, are there changes afoot!

https://jdc.jefferson.edu/jss/vol5/iss1/11
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Center director Gordon Schwartz, MD, MBA, FACS and assistant director Sun Yong (Sunny)
Lee, MD, FACS lead the multidisciplinary team of the new Jefferson Breast Care Center.

The New Breast Care
Center: Truly “Managed
Care” for Women
In a few short months, the Jefferson Breast
Care Center has already distinguished
itself nationally. Formally launched on
October 1, 2009, with the appointment
of Gordon Schwartz, MD, MBA, FACS
as Center Director, the Center also
received a full, 3-year accreditation from
the National Accreditation Program for
Breast Care Centers (NABCC) after a
rigorous evaluation.
The Center offers a unique approach to
the care of any woman with questions
related to breast health. “We want to
serve people with specific diagnoses, but
also strengthen our commitment to those
whom we call ‘the worried well’,” says
Dr. Schwartz, a Professor of Surgery.

“We want to serve people
with specific diagnoses,
but also strengthen
our commitment to
those whom we call
‘the worried well’”
The Center’s multidisciplinary approach
integrates surgery, medicine, oncology,
and radiation oncology, as well as
integrative (and holistic) medicine and
emotional support for women and their
families. The Jefferson model coordinates
and streamlines the process for patients,

to avoid what one patient described as her
experience elsewhere of “being treated by
4 or 5 subcontractors, when what I really
wanted was a general contractor.”
The team of Jefferson specialists includes
the new Assistant Director, Sun Yong
Lee, MD, FACS who completed a breast

are Vascular Surgery Nurse Practitioners
for the outpatient and inpatient practices
(respectively). They both assumed their
positions in late spring of 2009.
What does an average day look like?
Katie: Between the vascular attending

physicians and me, we see 40 patients
a day in a fast-paced outpatient office.
I perform patient history and physicals
and develop a plan of care in conjunction
with the attendings, to improve patient
education and communication. I follow
wound care patients and occasionally
manage insurance issues. We work closely
with the anticoagulation clinic and the
hyperbaric treatment center.

Dr. Schwartz is committed to making
the most of what scientists are doing
across campus, “by integrating basic
science results into our practice as soon
as possible.” The Center will also have an
international board of advisors, including
the world-renowned Italian breast cancer
surgeon Umberto Veronesi, MD, and
others from Italy, France and the United
Kingdom, making Jefferson a site for
international collaboration.

Brody Recognized for Promising
Pancreatic Cancer Research

The long-term plan for the center is to
expand upon the Breast Imaging Center
on the 4th floor of the Medical Office
Building at 11th and Walnut Streets in
Center City by adding a clinical facility
one floor below. From its leadership to
individual technicians, the Center staff
strives to serve as a lifelong family for its
patients. “The women we treat will have a
home with us forever,” says Dr. Schwartz.

Assistant Professor Jonathan Brody,
PhD, has received a prestigious Career
Development Award from the Pancreatic
Cancer Action Network (PanCAN) and
the American Association for Cancer
Research (AACR) for his innovative
research in pancreatic cancer.

For more information about the Breast Care
Center visit: www.jeffersonhospital.org/breast

“The results have the
potential to help us
learn how to customize
treatments for patients
to improve outcomes
and survival.”

Joyce Hartmann, Physician Liaison
for Liver Transplant Program
This fall marked the 25th anniversary
of the region’s first liver transplant –
performed at Jefferson – and since then,
Joyce Hartmann has had the opportunity
to represent Jefferson’s Liver Transplant
Program to referring physicians throughout
the Delaware Valley.

Jefferson’s Liver Transplant Program
consistently surpasses national averages
for transplantation survival rates,” Joyce
explains. “Our surgeons transplant the
sickest patients in the region and our
program has the lowest mortality rate
among patients on the recipient waiting list.
It is a privilege to represent the team, to

Shawn: I work with the vascular team

Jonathan Brody, PhD, and his team of technicians, residents and students are
conducting studies that are garnering financial support for a historically underfunded
field of research – pancreatic cancer.

Please Welcome

With 20 years of healthcare marketing
and program development experience,
Joyce was attracted to the position
because of the chance to represent the
multidisciplinary team of physicians
and surgeons, transplant coordinators,
social workers and support staff.

On the Job

One of three Career Development Awards
granted to junior faculty at academic and
medical institutions each year, Dr. Brody’s
award is named for the philanthropist and
Rydex Investments founder Skip Viragh,
who died of pancreatic cancer in 2003.
Dr. Brody accepted the award at a formal
ceremony held on April 20 at the annual
meeting of the AACR in Washington,
DC. He will receive $200K over the next
two years.

ensure that their talents are known to referring
physicians and patients receive the care that
they need.”
To coordinate an office visit and for
assistance with patient navigation or
scheduling an appointment, please
contact Joyce at 215-503-7507 or
joyce.hartmann@jeffersonhospital.org.

“While the need for scientific and
medical breakthroughs in pancreatic
cancer research is urgent, there is a
major shortage of federal funding for
research on this deadly disease,” says
Julie Fleshman, President and CEO of
PanCAN. “Since 1999, PanCAN has been
working to help fill this critical void. In
2010, we will disburse nearly $2.3 million
in funding for research grants. We are
excited about this partnership with
Dr. Brody and look forward to working
with him as we make strides against
this deadly disease.”

comprised of an intern, a resident, a
fellow and Drs. Paul DiMuzio and Joshua
Eisenberg. Together we manage patients
in surgery as well as on the floor. I work
closely with our case manager on more
complicated discharge cases. After
patients leave, I call to help with questions
or complications.

Surgical Intensive Care Unit for 3½ years.
I earned my master’s degree at Jefferson
during that time.
Shawn: I have been a nurse for 23 years

and I taught for 10, so many of the nurses
here know me as an instructor. I worked
as a critical care “float” RN working in
the Intensive Care Units and the Post
Anesthesia Care Unit as needed.
Do the two of you work together?

What are your respective backgrounds?

Shawn: We share an office and often

Katie: I worked as a nurse at Jefferson for

confer with each other to improve
continuity in patient care. Patients
appreciate how well we know them.

5 years, including the Intermediate Surgical
Intensive Care Unit for 18 months and the

author and Jefferson pathologist Dr.
Agnieszka Witkiewicz closely collaborated
on, were first published as a Priority
Report in the journal Cancer Research in
June 2009. A follow up report is being
presented this month at the American
Surgical Association in Chicago.

Dr. Brody will use the funding to build
upon his research on a stress-response
protein called Hu antigen R (HuR),
“activated” in pancreatic tumor cells.
Dr. Brody and his team have found
that HuR can actually be used to
predict the effectiveness of the standard
chemotherapy treatment for pancreatic
cancer: gemcitabine.

“By improving our understanding of
drug metabolism and the molecular
diversity that exists within the patient
population, this study has important
implications for the development of
personalized medicine for pancreatic
cancer,” notes Ms. Fleshman. “The results
have the potential to help us learn how
to customize treatments for patients to
improve outcomes and survival.”

“This means that HuR is essentially
a biomarker, which we can use to
determine up front whether a patient is
likely to respond to this treatment or not,”
says Dr. Brody. The findings of his initial
study, of which Dr. Brody was the senior

Dr. Brody and his team are now seeking a
way to activate HuR in patients that show
low levels of the protein. “The research
is moving into expanding our clinical
samples as well as building on pre-clinical
animal models for further exploration,”

says Dr. Brody. “We are intrigued as to
whether other chemotherapeutic agents
might also engage this same pathway.”
“As a young pancreatic cancer researcher
I have always admired these two topnotch organizations,” says Dr. Brody,
“and to be recognized by them truly is
an honor and validates the direction of
my research.” This award allows him to
produce a body of high-quality data over
the next few years as he strives to extend
his funding and work with the aid of such
agencies as the National Cancer Institute
(NCI). Ultimately, Dr. Brody hopes this
funding will help translate the work in his
laboratory for the benefit of pancreatic
cancer patients in the clinical setting.
[Editor’s note: Dr. Brody has, as of this
writing, just been notified that he has
been awarded an American Cancer Society
grant in excess of $700k over the next
4 years.]

For more information about the
Liver Transplant Program visit:
www.jeffersonhospital.org/transplant/liver
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as Center Director, the Center also
received a full, 3-year accreditation from
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Breast Care Centers (NABCC) after a
rigorous evaluation.
The Center offers a unique approach to
the care of any woman with questions
related to breast health. “We want to
serve people with specific diagnoses, but
also strengthen our commitment to those
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integrative (and holistic) medicine and
emotional support for women and their
families. The Jefferson model coordinates
and streamlines the process for patients,

to avoid what one patient described as her
experience elsewhere of “being treated by
4 or 5 subcontractors, when what I really
wanted was a general contractor.”
The team of Jefferson specialists includes
the new Assistant Director, Sun Yong
Lee, MD, FACS who completed a breast

Dr. Schwartz is committed to making
the most of what scientists are doing
across campus, “by integrating basic
science results into our practice as soon
as possible.” The Center will also have an
international board of advisors, including
the world-renowned Italian breast cancer
surgeon Umberto Veronesi, MD, and
others from Italy, France and the United
Kingdom, making Jefferson a site for
international collaboration.
The long-term plan for the center is to
expand upon the Breast Imaging Center
on the 4th floor of the Medical Office
Building at 11th and Walnut Streets in
Center City by adding a clinical facility
one floor below. From its leadership to
individual technicians, the Center staff
strives to serve as a lifelong family for its
patients. “The women we treat will have a
home with us forever,” says Dr. Schwartz.
For more information about the Breast Care
Center visit: www.jeffersonhospital.org/breast
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for Liver Transplant Program
This fall marked the 25th anniversary
of the region’s first liver transplant –
performed at Jefferson – and since then,
Joyce Hartmann has had the opportunity
to represent Jefferson’s Liver Transplant
Program to referring physicians throughout
the Delaware Valley.
With 20 years of healthcare marketing
and program development experience,
Joyce was attracted to the position
because of the chance to represent the
multidisciplinary team of physicians
and surgeons, transplant coordinators,
social workers and support staff.
Jefferson’s Liver Transplant Program
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explains. “Our surgeons transplant the
sickest patients in the region and our
program has the lowest mortality rate
among patients on the recipient waiting list.
It is a privilege to represent the team, to

ensure that their talents are known to referring
physicians and patients receive the care that
they need.”
To coordinate an office visit and for
assistance with patient navigation or
scheduling an appointment, please
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joyce.hartmann@jeffersonhospital.org.
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Brody Recognized for Promising
Pancreatic Cancer Research
Assistant Professor Jonathan Brody,
PhD, has received a prestigious Career
Development Award from the Pancreatic
Cancer Action Network (PanCAN) and
the American Association for Cancer
Research (AACR) for his innovative
research in pancreatic cancer.

“The results have the
potential to help us
learn how to customize
treatments for patients
to improve outcomes
and survival.”
One of three Career Development Awards
granted to junior faculty at academic and
medical institutions each year, Dr. Brody’s
award is named for the philanthropist and
Rydex Investments founder Skip Viragh,
who died of pancreatic cancer in 2003.
Dr. Brody accepted the award at a formal
ceremony held on April 20 at the annual
meeting of the AACR in Washington,
DC. He will receive $200K over the next
two years.
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Intensive Care Unit for 18 months and the

author and Jefferson pathologist Dr.
Agnieszka Witkiewicz closely collaborated
on, were first published as a Priority
Report in the journal Cancer Research in
June 2009. A follow up report is being
presented this month at the American
Surgical Association in Chicago.

Dr. Brody will use the funding to build
upon his research on a stress-response
protein called Hu antigen R (HuR),
“activated” in pancreatic tumor cells.
Dr. Brody and his team have found
that HuR can actually be used to
predict the effectiveness of the standard
chemotherapy treatment for pancreatic
cancer: gemcitabine.

“By improving our understanding of
drug metabolism and the molecular
diversity that exists within the patient
population, this study has important
implications for the development of
personalized medicine for pancreatic
cancer,” notes Ms. Fleshman. “The results
have the potential to help us learn how
to customize treatments for patients to
improve outcomes and survival.”

“This means that HuR is essentially
a biomarker, which we can use to
determine up front whether a patient is
likely to respond to this treatment or not,”
says Dr. Brody. The findings of his initial
study, of which Dr. Brody was the senior

Dr. Brody and his team are now seeking a
way to activate HuR in patients that show
low levels of the protein. “The research
is moving into expanding our clinical
samples as well as building on pre-clinical
animal models for further exploration,”

says Dr. Brody. “We are intrigued as to
whether other chemotherapeutic agents
might also engage this same pathway.”
“As a young pancreatic cancer researcher
I have always admired these two topnotch organizations,” says Dr. Brody,
“and to be recognized by them truly is
an honor and validates the direction of
my research.” This award allows him to
produce a body of high-quality data over
the next few years as he strives to extend
his funding and work with the aid of such
agencies as the National Cancer Institute
(NCI). Ultimately, Dr. Brody hopes this
funding will help translate the work in his
laboratory for the benefit of pancreatic
cancer patients in the clinical setting.
[Editor’s note: Dr. Brody has, as of this
writing, just been notified that he has
been awarded an American Cancer Society
grant in excess of $700k over the next
4 years.]

For more information about the
Liver Transplant Program visit:
www.jeffersonhospital.org/transplant/liver

Published by Jefferson Digital Commons, 2010

For an appointment with a Jefferson Surgeon, call 1- 800 - JEFF - NOW

3

Jefferson Surgical Solutions, Vol. 5 [2010], Iss. 1, Art. 11

News in Brief

Jefferson Awards
Gala Celebrates
a Dedicated
Faculty Member
On October 22, 2009, the
Jefferson community celebrated
the contributions of Herbert E.
Cohn, MD, FACS, at the Seventh
Annual Jefferson Awards Gala. Dr.
Cohn, a Jefferson Medical College
alumnus, distinguished member of
the Department of Surgery faculty,
teacher and administrative leader,
received the Achievement Award in
Medicine, recognizing his career in
thoracic and endocrine surgery.
More than 500 guests attended
the event which raised close to
$600,000 for Jefferson. Among the
many alumni, faculty and friends who
generously supported the Gala was
Mrs. Irmine Pilmes, a longtime patient
of Dr. Cohn’s. Dr. Cohn cared for
both she and her husband, Alexander
Bondaretz, over many years and
earned their deep appreciation. When
Mrs. Pilmes learned of the Gala,
she decided to make a significant
contribution to Jefferson in Dr.
Cohn’s honor. For Mrs. Pilmes, the
best vehicle for such a gift was
through her estate. She worked with
the Jefferson Foundation and her
attorney to develop language in her
will that would direct $100,000 to
the Department of Surgery in support
of thoracic and endocrine surgery
education and research.

Nathaniel R. Evans, MD has joined the
Division of Cardiothoracic Surgery.
Dr. Evans finished his cardiothoracic
surgery training at the Massachusetts
General Hospital in December 2009.
His focus will be on thoracic surgery
both at Thomas Jefferson University
Hospital and Methodist Hospital.

SurgicalSolutions
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Those Who Give

Kidney Transplant Program Offers Many
Options and Encourages Living Donors

Nathaniel R. Evans, MD

Sun Yong (Sunny) Lee, MD, FACS

Dr. Cohn (center) accepts the Academic Achievement Award from
University President Robert Barchi, MD, PhD (left) and Tom Lewis,
TJUH President and CEO. Three generations of Dr. Cohn’s family
attended the event last fall, including his wife Natalie (below.)

The most common form of a planned
gift is a simple bequest through a
will. Bequests of cash, securities,
real property or other assets to

Jefferson entitle one’s estate to a
charitable deduction that can reduce
or eliminate estate tax liability.
Sadly, Mrs. Pilmes was unable
to attend the Gala in the fall. She
passed away during the summer, but
was recognized at the event for her
tremendous generosity as a Platinum
Sponsor. Dr. Cohn, who is currently

the Vice Chair of Quality, humbly
recalls, “I have received many gifts
from grateful patients over the years
from bottles of scotch to bequests
in their wills and I’m always taken
aback – I’m just doing my job.” At the
same time, he is very appreciative.
“It is fitting that Jefferson received
this gift. This is where I trained and
practiced my entire career. Mrs.
Pilmes’ generous gift will help ensure
that Jefferson continues to produce
top-notch surgeons and push our
research forward.”
For additional information about
planned giving, or to make a
contribution to the Department of
Surgery, please contact Lara Goldstein
in the Jefferson Foundation
at 215-955-8797 or
lara.goldstein@jefferson.edu.

has joined the Division of General Surgery. In 2005, Dr. Lee
completed a fellowship in breast surgery here at Thomas Jefferson
University Hospital. She is the Assistant Director of the new
Jefferson Breast Care Center.
Kris R. Kaulback, MD, FACS has been appointed medical director of

Philadelphia is a competitive community
for kidney transplantation, and yet
Jefferson’s 2009 numbers were
impressive: 93 kidney and kidneypancreas transplants. “Thirty-two of these
transplanted organs were from living
donors,” says Associate Professor Carlo B.
Ramirez, MD, FACS. “The percentage of
living donors grew by 19 percent last year,
while the percentage of deceased donors
remained the same as the previous year.”

the trauma program at Paoli Hospital. Dr. Kaulback will also continue
as the associate director of the Level I trauma unit at Jefferson.

Adam Berger, MD, FACS, recently received an Outstanding

Performance Award for going above and beyond the scope of the
normal duties of serving as a liaison between the Hospital’s cancer
program and the American College of Surgeons Commission on
Cancer (CoC).

Nathan Richards, MD (PGY4) presented his work from Dr.

Jonathan Brody’s lab on HuR status and pancreatic cancer at the
130th Annual Meeting of the American Surgical Association in
Chicago this April.

Berch Harris is a Jefferson patient who
was fortunate to know a donor with
whom he was a good match—his wife.
He met Vallerie Armstrong in 2002
when he started hemodialysis at a center
where she worked. Three years later,
Berch had regained kidney function on
two separate occasions, and he stopped
by the center with information about a
product that had helped him. Vallerie
gave him her number—it was her last
day of work there. They started dating in
2006, began doing at-home dialysis the
following spring and married in Berch’s
native Barbados on December 8, 2007.
By that time Vallerie had been tested
and deemed a match with Berch. With
his history of regaining function, Berch
remained optimistic that his kidney would
once again kick in. But those hopes were
dashed when doctors found a cancerous
tumor on his left kidney. That’s when
he and Vallerie knew it was time to get
serious about transplantation.

Melissa Lazar, MD (PGY4) has won a resident research award

from the Society for Surgery of the Alimentary Tract and will
present at the May meeting on her work in Dr. Hwyda Arafat’s
lab on osteopontin and nicotine.

Steven McIlhenny, defended his PhD thesis in Jefferson’s

Tissue Engineering and Regenerative Medicine Program. Under
the mentorship of Dr. Paul J. DiMuzio, Dr. McIlhenny was
previously awarded a prestigious American Heart Association
Pre-doctoral Fellowship.

On Thursday, December 3, 2009, the portrait of Gerald J. Marks,
MD, FACS, was presented to Thomas Jefferson University. A
member of the Jefferson faculty for many years, Dr. Marks has
led a distinguished surgical career and has made numerous
contributions to the field of colorectal surgery.
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After having his left kidney removed
in July 2008, Berch and Vallerie moved
forward with their plan to pursue live
donor transplant. In February 2009,
Costas Lallas, MD, performed a robotic
nephrectomy on Vallerie and Dr. Ramirez
(whom she describes as “a fabulous
human being”) transplanted the kidney
to Berch. “We’re very blessed that we
have been afforded this opportunity,” says
Vallerie. “Life’s just better now, and will
continue to get better.”
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The Surgeon Speaks

Carlo Ramirez, MD, FACS

Though the heart is the universal symbol for love, for Berch and Vallerie Harris, the kidney
might be a more fitting representation of their shared affection, perseverance and faith.

Dr. Ramirez and three other Jefferson
surgeons perform kidney transplants:
Cataldo Doria, MD, PhD, FACS, the
Nicoletti Family Professor of Transplant
Surgery and Director of the Transplant
Division; Assistant Professor Adam
Frank, MD, FACS; and Associate
Professor Warren Maley, MD, who is
also Director of the Live Donor Liver
Transplantation (LDLT) Program, which
launches this spring. For patients less
fortunate than Mr. Harris, Jefferson
offers other options, including deceased
donor and paired donation protocols (see
sidebar).
Dr. Ramirez explains that, as one of
6 kidney transplant programs in the
city of Philadelphia, Jefferson strives
to maximize its patients’ chances of
receiving a donor kidney. One key to

expanding Jefferson’s transplant list is
Outreach and Education Coordinator
Kim Phillips, RN, BSN, CCTC, who goes
out to nephrology practices around the
Delaware Valley, to build relationships
and coordinate meetings with Jefferson
surgeons. “This enables us to get know
the nephrologists who refer patients to
us,” says Dr. Ramirez, “and it fosters
good communication. The day after a
transplant I always call the referring
nephrologist to let them know how their
patient is recovering,” he notes. “I find
that keeping in touch like this means a
significant amount—as it does to me with
my own patients.”
For more information about the
Kidney Transplant Program visit:

Transplantation from living donors offers
the best outcomes for patients with chronic
kidney disease. Unfortunately, only 60
percent of potential living donors are
compatible with their intended recipients.
Those patients without a compatible donor
will have to wait on the deceased donor
transplant list, which currently exceeds
85,000 patients nationally, with a median
wait time of 4 years.
To facilitate living kidney donor exchanges,
Jefferson has adopted a “paired-kidney
donation” (or “kidney donor swap”)
protocol, which will help patients with
potential living donors who are incompatible
for blood or tissue type. By collaborating
with the Paired Donation Network, we hope
to find a compatible donor-recipient pair
that will make transplant possible for most
of these recipients.
The surgery is identical to a standard living
donor kidney transplant, but there are added
considerations with a kidney exchange:
the timing of the donor operations requires
careful coordination to avoid an unfair
exchange, where one donor donates while
another potential donor does not, resulting
in only one recipient getting a transplant.

www.jeffersonhospital.org/transplant/kidney
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